Research output per year
Research output per year
Fingerprint
Dive into the research topics where Tine Lottenburger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Researchers
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Circadian, Week-to-Week, and Physical Exercise-Induced Variation of Serum Microfibrillar-Associated Protein 4
Sækmose, S. G., Holst, R., Lottenburger, T., Ytting, H., Nielsen, H. J., Junker, P., Schlosser, A. & Sorensen, G. L., 14. May 2021, In: Biomarker Insights. 16Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile32 Downloads (Pure) -
Komplet remission ved behandling med JAK-hæmmer hos en patient med alopeciatotalis
Translated title of the contribution :Successful treatment of alopecia totalis with tofacitinib in a Danish patient Research output: Contribution to journal › Journal article › Research › peer-review
-
Rheumatoid arthritis treatment associated changes in circulating bone-turnover markers
The CIMESTRA Study Group, Oct 2020, In: Bone Reports. 13, Suppl., p. 2-3 P010.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial
Brahe, C. H., Østergaard, M., Johansen, J. S., Defranoux, N., Wang, X., Bolce, R., Sasso, E., Ørnbjerg, L., Hørslev-Petersen, K., Stengaard-Pedersen, K., Junker, P., Ellingsen, T., Ahlquist, P., Lindegaard, H., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I., Lottenburger, T. & Ammitzbøll, C. & 4 others, , 2. Jan 2019, In: Scandinavian Journal of Rheumatology. 48, 1, p. 9-16Research output: Contribution to journal › Journal article › Research › peer-review
-
Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA trials
Brahe, C. H., Dehlendorff, C., Østergaard, M., Johansen, J. S., Ørnbjerg, L. M., Hørslev-Petersen, K., Stengaard-Pedersen, K., Junker, P., Ellingsen, T., Lindegaard, H., Hansen, I., Lottenburger, T., Jacobsen, S., Jurik, A. G. & Hetland, M. L., 4. Jul 2018, In: Scandinavian Journal of Rheumatology. 47, 4, p. 259-269Research output: Contribution to journal › Journal article › Research › peer-review
Activities
-
Short- and long-term effect of unguided, intra-articular injections with betamethasone in early rheumatoid arthritis.: Impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP
Lottenburger, T. (Lecturer)
25. May 2011 → 28. May 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
Gigt i 2008
Lottenburger, T. (Lecturer)
5. Nov 2008Activity: Talks and presentations › Talks and presentations in private or public companies
-
Dansk Reumatologisk Selskabs bestyrelse (External organisation)
Lottenburger, T. (Member)
11. Apr 2008 → 2018Activity: Membership › Membership of commitees, commissions, boards, councils, associations, organisations, or similar
-
Dansk Reumatologisk Selskabs møde- og efteruddannelsesudvalg (External organisation)
Lottenburger, T. (Member)
15. Sept 2007 → 2018Activity: Membership › Membership of commitees, commissions, boards, councils, associations, organisations, or similar
-
(1862) Continuous Excellent Treatment Response to Aggressive Combination Therapy in Early Rheumatoid Arthritis. Year Two Results from the Cimestra Study, an Investigator-Initiated, Randomised, Controlled, Double-Blinded Study of Methotrexate, Intraarticular Corticosteroid and Cyclosporine or Placebo-Cyclosporine
Lottenburger, T. (Speaker)
2005Activity: Talks and presentations › Talks and presentations in private or public companies